Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of the combination of abemaciclib
and fulvestrant in treating this type of cancer and to determine the types and severity of
side effects caused by treatment with abemaciclib and fulvestrant.